Asija S - Search Results

1

Status of functional neurosurgery in lower middle-income countries (LMICs): A multinational cross sectional survey based analysis of exposure, utilization and perceived barriers.

Asija S, Pahwa B, Agarwal A, Patil Y, Chaurasia B. Asija S, et al. Clin Neurol Neurosurg. 2024 Oct;245:108411. doi: 10.1016/j.clineuro.2024.108411. Epub 2024 Jul 9. Clin Neurol Neurosurg. 2024. PMID: 39089202

2

Bluff Indicators in Medical and Dental Tele-Consultation: A Review.

Jethi N, Asija S, Pandav G, Kaur S, Garg M, Kaur S. Jethi N, et al. Among authors: asija s. J Pharm Bioallied Sci. 2024 Apr;16(Suppl 2):S1048-S1050. doi: 10.4103/jpbs.jpbs_874_23. Epub 2024 Apr 16. J Pharm Bioallied Sci. 2024. PMID: 38882872 Free PMC article. Review.

3

The intricate role of lipids in orchestrating plant defense responses.

Seth T, Asija S, Umar S, Gupta R. Seth T, et al. Among authors: asija s. Plant Sci. 2024 Jan;338:111904. doi: 10.1016/j.plantsci.2023.111904. Epub 2023 Nov 3. Plant Sci. 2024. PMID: 37925973 Review.

4

CAR-T cell therapy in hematological malignancies: Where are we now and where are we heading for?

Khan AN, Asija S, Pendhari J, Purwar R. Khan AN, et al. Among authors: asija s. Eur J Haematol. 2024 Jan;112(1):6-18. doi: 10.1111/ejh.14076. Epub 2023 Aug 7. Eur J Haematol. 2024. PMID: 37545253 Review.

5

Oncolytic immunovirotherapy for high-grade gliomas: A novel and an evolving therapeutic option.

Asija S, Chatterjee A, Goda JS, Yadav S, Chekuri G, Purwar R. Asija S, et al. Front Immunol. 2023 Mar 15;14:1118246. doi: 10.3389/fimmu.2023.1118246. eCollection 2023. Front Immunol. 2023. PMID: 37006286 Free PMC article. Review.

6

Clinical utility of CAR T cell therapy in brain tumors: Lessons learned from the past, current evidence and the future stakes.

Chatterjee A, Asija S, Yadav S, Purwar R, Goda JS. Chatterjee A, et al. Among authors: asija s. Int Rev Immunol. 2022;41(6):606-624. doi: 10.1080/08830185.2022.2125963. Epub 2022 Oct 3. Int Rev Immunol. 2022. PMID: 36191126 Review.

7

Combinatorial approaches to effective therapy in glioblastoma (GBM): Current status and what the future holds.

Asija S, Chatterjee A, Yadav S, Chekuri G, Karulkar A, Jaiswal AK, Goda JS, Purwar R. Asija S, et al. Int Rev Immunol. 2022;41(6):582-605. doi: 10.1080/08830185.2022.2101647. Epub 2022 Aug 8. Int Rev Immunol. 2022. PMID: 35938932 Review.

8

Immunogenicity of CAR-T Cell Therapeutics: Evidence, Mechanism and Mitigation.

Khan AN, Chowdhury A, Karulkar A, Jaiswal AK, Banik A, Asija S, Purwar R. Khan AN, et al. Among authors: asija s. Front Immunol. 2022 May 23;13:886546. doi: 10.3389/fimmu.2022.886546. eCollection 2022. Front Immunol. 2022. PMID: 35677038 Free PMC article. Review.

9

Robust Antitumor Activity and Low Cytokine Production by Novel Humanized Anti-CD19 CAR T Cells.

Dwivedi A, Karulkar A, Ghosh S, Srinivasan S, Kumbhar BV, Jaiswal AK, Kizhakeyil A, Asija S, Rafiq A, Kumar S, Nisar A, Patil DP, Poojary MV, Jain H, Banavali SD, Highfill SL, Stroncek DF, Shah NN, Fry TJ, Narula G, Purwar R. Dwivedi A, et al. Among authors: asija s. Mol Cancer Ther. 2021 May;20(5):846-858. doi: 10.1158/1535-7163.MCT-20-0476. Epub 2021 Feb 25. Mol Cancer Ther. 2021. PMID: 33632869

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

9 results

Search Page

Filters